Literature DB >> 23504142

The acceleration in papillary thyroid cancer incidence rates is similar among racial and ethnic groups in the United States.

Briseis Aschebrook-Kilfoy1, Edwin L Kaplan, Brian C-H Chiu, Peter Angelos, Raymon H Grogan.   

Abstract

BACKGROUND: Reports of similar age-specific incidence rates and a female-to-male gender disparity by racial/ethnic groups suggests that further consideration of race-specific patterns may confer insight into the possible causes of thyroid cancer or explanations for the increase in incidence.
METHODS: We used the National Cancer Institute's (NCIs) surveillance, epidemiology, and end results (SEER) program and Joinpoint Regression for cases diagnosed during 1992-2009 to investigate trends and rates of acceleration for papillary thyroid cancer by gender and race/ethnicity.
RESULTS: We determined the annual percent change (APC) and found a yearly increase of 7.0 % for papillary thyroid cancer for the most recent APC trend, with an APC of 6.3 and 7.1 % for white males and females, respectively; an APC of 4.3 and 8.4 % for black males and females, respectively; an APC of 4.2 and 6.7 % for Hispanic males and females, respectively; and an APC of 3.4 and 6.4 % in Asian/PI males and females, respectively. The APC projections show the rates of papillary thyroid cancer rising in males, but the patterns are more dramatic in females, with rates of papillary thyroid cancer in females surpassing rates of common cancers and becoming the third most common cancer in women of all ages by 2019.
CONCLUSIONS: Although the lowest rates of thyroid cancer are observed in blacks, the greatest rate of acceleration is occurring in black females. Our data also show that the rate of papillary thyroid cancer will continue to surpass rates of ovarian cancer, and in white women: it is projected to be more incident than colorectal cancer as well; and in Hispanic and Asian/Pacific Islander women, rates of papillary thyroid cancer are projected to be higher than lung, colorectal, and ovarian cancers in the near future.

Entities:  

Mesh:

Year:  2013        PMID: 23504142     DOI: 10.1245/s10434-013-2892-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  26 in total

1.  Cancer-related worry in Canadian thyroid cancer survivors.

Authors:  Lauren Bresner; Rita Banach; Gary Rodin; Lehana Thabane; Shereen Ezzat; Anna M Sawka
Journal:  J Clin Endocrinol Metab       Date:  2014-11-13       Impact factor: 5.958

Review 2.  The changing incidence of thyroid cancer.

Authors:  Cari M Kitahara; Julie A Sosa
Journal:  Nat Rev Endocrinol       Date:  2016-07-15       Impact factor: 43.330

Review 3.  Growing incidence of thyroid carcinoma in recent years: Factors underlying overdiagnosis.

Authors:  Alvaro Sanabria; Luiz P Kowalski; Jatin P Shah; Iain J Nixon; Peter Angelos; Michelle D Williams; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck       Date:  2017-12-05       Impact factor: 3.147

4.  Occurrence of Endocrine and Thyroid Cancers Among Alaska Native People, 1969-2013.

Authors:  Sarah H Nash; Anne P Lanier; Molly B Southworth
Journal:  Thyroid       Date:  2018-03-19       Impact factor: 6.568

5.  Sociodemographic disparities in differentiated thyroid cancer survival among adolescents and young adults in California.

Authors:  Theresa H M Keegan; Raymon H Grogan; Helen M Parsons; Li Tao; Michael G White; Kenan Onel; Pamela L Horn-Ross
Journal:  Thyroid       Date:  2015-04-20       Impact factor: 6.568

6.  Obesity and the risk of papillary thyroid cancer: a pooled analysis of three case-control studies.

Authors:  Li Xu; Matthias Port; Stefano Landi; Federica Gemignani; Monica Cipollini; Rossella Elisei; Lilia Goudeva; Jörg Andreas Müller; Kai Nerlich; Giovanni Pellegrini; Christoph Reiners; Cristina Romei; Robert Schwab; Michael Abend; Erich M Sturgis
Journal:  Thyroid       Date:  2014-05-05       Impact factor: 6.568

7.  Increasing incidence of thyroid cancer in the Commonwealth of Pennsylvania.

Authors:  Darrin V Bann; Neerav Goyal; Fabian Camacho; David Goldenberg
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2014-12       Impact factor: 6.223

8.  Incidence and Survival in Reproductive-Aged Women with Differentiated Thyroid Cancer: United States SEER 18 2000-2016.

Authors:  Emily Hughes Douglas; Anthony Rhoads; Alexandra Thomas; Joseph Aloi; Jonathan Suhl; Thomas Lycan; Jacob Oleson; Kristin M Conway; Joanna Klubo-Gwiezdzinska; Charles F Lynch; Paul A Romitti
Journal:  Thyroid       Date:  2020-06-10       Impact factor: 6.568

Review 9.  Quality of Life in Thyroid Cancer is Similar to That of Other Cancers with Worse Survival.

Authors:  Megan K Applewhite; Benjamin C James; Sharone P Kaplan; Peter Angelos; Edwin L Kaplan; Raymon H Grogan; Briseis Aschebrook-Kilfoy
Journal:  World J Surg       Date:  2016-03       Impact factor: 3.352

10.  Racial and socioeconomic disparities in presentation and outcomes of well-differentiated thyroid cancer.

Authors:  Avital Harari; Ning Li; Michael W Yeh
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.